OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK) (the “Company”) today announced that it is commencing a private offering of $200.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “Notes”). The Company also expects to grant the initial purchaser in the offering an option to purchase, within the 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $30.0 million aggregate principal amount of the Notes.
Related news for (OPK)
- OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
- OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
- OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
- OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
- OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results